U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Guidelines and Recommendations

CDC Stacks Public Health Publications

CDC Guidelines and Recommendations are updated by various CDC centers and institutes in response to new scientific discoveries, to public health issues, and to disease outbreaks. Items in this collection may have been superceded or replaced. For the most up to date information, please visit the CDC home page at https://www.cdc.gov/ and search the Health Topic or Outbreak you are interested in.

(5)
(2)
(4)
(3)
(2)
(3)
(17)
(10)
(16)
(13)
(27)
(33)
(21)
(46)
(33)
(34)
(34)
(22)
(25)
(18)
(19)
(27)
(21)
(29)
(13)
(15)
(17)
(14)
(12)
(10)
(13)
(15)
(12)
(14)
(11)
(16)
(16)
(6)
(1)
(3)
(3)
(6)
(3)
(1)
(4)
(27)
(22)
(30)
(8)
(9)
(7)
(7)
0 of 52
(123)
(27)
(1)
(1)
(626)
0 of 5
(1)
(1)
(3)
(2)
(1)
(30)
(1)
(7)
(1)
(3)
(7)
(1)
(1)
(1)
(104)
(1)
(1)
(7)
(3)
(2)
(1)
(1)
(45)
(1)
(117)
(8)
(51)
(2)
(29)
(5)
(4)
(1)
(1)
(1)
(2)
(413)
(2)
(5)
(13)
(2)
(1)
0 of 41
(7)
(2)
(39)
(3)
(2)
(2)
(7)
0 of 7
(53)
(6)
(5)
(1)
(3)
(12)
(563)
(1)
(1)
(22)
(41)
(63)
0 of 12
(449)
(1)
(31)
(270)
(1)
0 of 5
(130)
(18)
0 of 2
(138)
(9)
(1)
0 of 3
(2)
(1)
(9)
(8)
(6)
(2)
(1)
(1)
(1)
(1)
(14)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(74)
(1)
(5)
(1)
(1)
(1)
(87)
(1)
(1)
(7)
(1)
(4)
(35)
(2)
(9)
(1)
(5)
(2)
(1)
(8)
(3)
(3)
(7)
(1)
(2)
(1)
(1)
(2)
(2)
(2)
(29)
(1)
(8)
(20)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(36)
(6)
(1)
(6)
(3)
(13)
(2)
(2)
(1)
(5)
(1)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(8)
(1)
(3)
(3)
(1)
(8)
(5)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(14)
(3)
(4)
(1)
(2)
(1)
(3)
(6)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(6)
(10)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(8)
(1)
(1)
(1)
(4)
(2)
(4)
(9)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(2)
(6)
(1)
(3)
(1)
(3)
(1)
(2)
(13)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(22)
(2)
(13)
(3)
(1)
(2)
(1)
(4)
(2)
(4)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(6)
(3)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(6)
(2)
(2)
(1)
(91)
(76)
(3)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(3)
(3)
(2)
(2)
(6)
(2)
(3)
(9)
(2)
(5)
(2)
(3)
(4)
(14)
(3)
(2)
(10)
(4)
(3)
(4)
(3)
(4)
(6)
(2)
(2)
(2)
(2)
(11)
(2)
(2)
(10)
(3)
(2)
(4)
(4)
(5)
(3)
(2)
(2)
(2)
(11)
(10)
(2)
(15)
(6)
(3)
(3)
(2)
(3)
(2)
(5)
(3)
(3)
(2)
(7)
(2)
(2)
(2)
(3)
(3)
(2)
(8)
(5)
(2)
(2)
(2)
(2)
(2)
(3)
(10)
(10)
(2)
(2)
(2)
(3)
(2)
(15)
(2)
(4)
(2)
(6)
(24)
(20)
(18)
(2)
(5)
(2)
(7)
(3)
(2)
(5)
(8)
(2)
(2)
(3)
(7)
(2)
(2)
(5)
(3)
(9)
(11)
(2)
(3)
(2)
(2)
(4)
(4)
(6)
(2)
(2)
(2)
(2)
(4)
(3)
(2)
(25)
(2)
(15)
(2)
(3)
(5)
(31)
(2)
(2)
(5)
(2)
(3)
(15)
(2)
(3)
(5)
(4)
(7)
(2)
(2)
(2)
(4)
(4)
(6)
(3)
(5)
(2)
(3)
(3)
(4)
(64)
(2)
(2)
(3)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(2)
(3)
(4)
(2)
(3)
(2)
(2)
(2)
(4)
(2)
(4)
(2)
(3)
(3)
(2)
(2)
(2)
(3)
(13)
(8)
(2)
(77)
(3)
(10)
(7)
(3)
(4)
(21)
(2)
(3)
(5)
(13)
(4)
(2)
(2)
(2)
(3)
(3)
(2)
(2)
(4)
(4)
(2)
(5)
(3)
(3)
(3)
(2)
(4)
(2)
(8)
(4)
(2)
(2)
(8)
(4)
(5)
(2)
(2)
(2)
(2)
(9)
(7)
(6)
(2)
(3)
(3)
(43)
(2)
(3)
(2)
(4)
(2)
(5)
(2)
(2)
(11)
(11)
(6)
(4)
(6)
(6)
(6)
(2)
(2)
(2)
(5)
(221)
(12)
(2)
(2)
(2)
(2)
(10)
(7)
(2)
(18)
(2)
(2)
(7)
(7)
(4)
(9)
(98)
(2)
(2)
(10)
(2)
(2)
(4)
(2)
(3)
(5)
(83)
(30)
(2)
(31)
(7)
(2)
(8)
(2)
(7)
(3)
(4)
(5)
(20)
(10)
(9)
(3)
(14)
(6)
(2)
(12)
(4)
(11)
(2)
(10)
(2)
(16)
(5)
(2)
(2)
(21)
(18)
(3)
(8)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(5)
(3)
(3)
(5)
(2)
(2)
(10)
(2)
(5)
(12)
(2)
(5)
(2)
(3)
(2)
(14)
(3)
(3)
(3)
(3)
(3)
(2)
(5)
(2)
(4)
(2)
(2)
(13)
(3)
(4)
(4)
(11)
(11)
(2)
(42)
(4)
(28)
(2)
(2)
(16)
(3)
(9)
(5)
(8)
(9)
(2)
(2)
(9)
(15)
(2)
(11)
(7)
(2)
(2)
(2)
(3)
(43)
(2)
(6)
(4)
(2)
(4)
(8)
(8)
(8)
(5)
(2)
(9)
(6)
(7)
(2)
(4)
(3)
(6)
(2)
(2)
(27)
(2)
(140)
(164)
(2)
(4)
(3)
(2)
(2)
(5)
(4)
(4)
(10)
(4)
(11)
(5)
(6)
(5)
(2)
(2)
(35)
(5)
(3)
(2)
(2)
(4)
(2)
(4)
(4)
(10)
(3)
(2)
(4)
(2)
(11)
(2)
(2)
(5)
(2)
(3)
(5)
(23)
(3)
(6)
(2)
(2)
(3)
(2)
(22)
(6)
(3)
(60)
(3)
(23)
(2)
(4)
(5)
(2)
(2)
(2)
(6)
(2)
(2)
(2)
(15)
(2)
(2)
(2)
(6)
(2)
(12)
(2)
(14)
(5)
(5)
(4)
(4)
(3)
(18)
(9)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(18)
(2)
(2)
(16)
(3)
(3)
(10)
(2)
(6)
(2)
(7)
(3)
(2)
(3)
(5)
(7)
(10)
(2)
(18)
(22)
(5)
(3)
(2)
(7)
(12)
(29)
(41)
(3)
(4)
(2)
(2)
(2)
(3)
(2)
(3)
(5)
(165)
(23)
(7)
(3)
(3)
(10)
(2)
(6)
(2)
(2)
(3)
(2)
(6)
(4)
(6)
(2)
(2)
(2)
(2)
(17)
(3)
(4)
(2)
(5)
(3)
(2)
(2)
(7)
(3)
(2)
(13)
(5)
(6)
(2)
(4)
(2)
(2)
(2)
(2)
(4)
(19)
(15)
(7)
(3)
(6)
(4)
(3)
(2)
(3)
(3)
(3)
(2)
(4)
(2)
(2)
(2)
(2)
(5)
(3)
(2)
(3)
(5)
(3)
(2)
(2)
(2)
(4)
(4)
(6)
(3)
(3)
(2)
(2)
(6)
(2)
(2)
(2)
(36)
(2)
(2)
(14)
(2)
(2)
(2)
(8)
(19)
(3)
(5)
(4)
(2)
(4)
(6)
(2)
(2)
(2)
(3)
(3)
(3)
(2)
(6)
(10)
(87)
(2)
(23)
(15)
(2)
(8)
(16)
(11)
(11)
(15)
(2)
(12)
(2)
(3)
(3)
(5)
(14)
(3)
(2)
(2)
(6)
(4)
(3)
(4)
(8)
(6)
(3)
(4)
(2)
(2)
(10)
(3)
(2)
(2)
(3)
(9)
(2)
(11)
(4)
(5)
(2)
(2)
(2)
(2)
(2)
(17)
(5)
(4)
(3)
0 of 1000
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(13)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(11)
(1)
(1)
(3)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(22)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(2)
(1)
(4)
(1)
(9)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(4)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(3)
(5)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(4)
(2)
(1)
(2)
(3)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(5)
(1)
(4)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(5)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(3)
(6)
(2)
(2)
(2)
(7)
(2)
(5)
(3)
(4)
(3)
(2)
(7)
(2)
(2)
(5)
(2)
(2)
(5)
(2)
(2)
(3)
(3)
(3)
(3)
(3)
(4)
(2)
(5)
(3)
(4)
(2)
(2)
(2)
(2)
(2)
(2)
(5)
(9)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(6)
(2)
(2)
(2)
(3)
(2)
(3)
(2)
(6)
(4)
(2)
(5)
(5)
(8)
(2)
(2)
(4)
(3)
(3)
0 of 1000
(1)
(6)
(1)
(1)
(3)
(19)
(1)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(17)
(8)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(26)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(276)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(6)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(13)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(11)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(4)
(2)
(4)
(5)
(2)
(5)
(2)
(3)
(1)
(22)
(1)
(3)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(8)
(1)
(1)
(2)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(5)
(1)
(1)
(1)
(1)
(10)
(1)
(3)
(1)
(4)
(4)
(4)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(7)
(6)
(4)
(9)
(18)
(1)
(2)
(1)
(1)
(1)
(4)
(6)
(1)
(1)
(4)
(3)
(1)
(1)
(1)
(4)
(1)
(1)
(15)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(4)
(1)
(2)
(1)
(8)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(8)
(3)
(7)
(1)
(1)
(144)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(8)
(1)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(3)
(12)
(122)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(9)
(1)
(1)
(3)
(1)
(1)
(1)
0 of 444
(1)
(1)
(9)
(4)
(1)
(1)
(2)
(89)
(3)
(2)
(40)
(230)
(1)
(25)
(1)
(81)
(1)
(26)
(2)
(4)
(146)
(1)
(1)
(4)
(1)
(4)
0 of 26
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 171
Showing 221 - 240 of 779 results
  • Aprobacin de la vacuna contra la influenza inactivada de dosis alta para personas 65 aos Fluzone de dosis alta y recomendaciones para el uso Estados Unidos 2010 MMWR 2010 59 16
    Aprobación de la vacuna contra la influenza inactivada de dosis alta para personas ≥65 años (Fluzone de dosis alta) y recomendaciones para el uso --- Estados Unidos, 2010. MMWR 2010; 59 (16)
    April 30, 2010 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Las personas ≥65 años presentan un riesgo mayor de hospitalización y muerte por la influenza estacional en comparación con otros grupos de edades y comparados con los adultos jóvenes, reaccionan a la vacunación con un nivel de anticuerpos menor a la hemaglutinina de la influenza (una correlación establecida de protección contra la influenza). El 23 ...
    Current Multi-Language Public Domain
  • Licensure of a highdose inactivated influenza vaccine for persons aged or 65 years Fluzone HighDose and guidance for use United States 2010 MMWR 201059 16 485486
    Licensure of a high-dose inactivated influenza vaccine for persons aged >or= 65 years (Fluzone High-Dose) and guidance for use -- United States, 2010. MMWR 2010;59 (16): 485-486.
    April 30, 2010 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Persons aged >or= 65 years are at greater risk for hospitalization and death from seasonal influenza compared with other age groups, and they respond to vaccination with lower antibody titers to influenza hemagglutinin (an established correlate of protection against influenza) compared with younger adults. On December 23, 2009, the Food and Drug Ad ...
    Current Supporting Files Multi-Language Public Domain
  • CDC recommendations for improving health through transportation policy
    CDC recommendations for improving health through transportation policy
    National Center for Environmental Health (U.S.)
    4/28/2010
    The U.S. transportation system has been shaped by multiple policy inputs and concrete actions which have arisen from transportation and community planners, funding agencies and others at Federal, state and local levels. Today, the system is designed to move people and goods efficiently; however, there is a growing awareness across communities that ...
    Current Public Domain
  • PHIN communication and alerting PCA guide Version 13
    PHIN communication and alerting (PCA) guide [Version 1.3]
    Centers for Disease Control and Prevention (U.S.). Public Health Information Network.
    April 27, 2010
    The CDC Public Health Information Network (PHIN) is a national initiative to improve the capacity of public health to use and exchange information electronically by promoting the use of standards, defining functional and technical requirements. PHIN Communication and Alerting (PCA), one component o f PHIN, is a specification o f public health alert ...
    Current Public Domain
  • A Call for action on the tuberculosis elimination plan for the United States
    A Call for action on the tuberculosis elimination plan for the United States
    Stop TB USA Tuberculosis Elimination Plan Committee  ...
    03/22/2010
    In 2000, the Institute of Medicine (IOM) published a report, Ending Neglect: The Elimination of Tuberculosis in the United States, detailing the history of efforts to control and eliminate tuberculosis in the United States and recommending a plan to eliminate tuberculosis in the United States by 2035. In 2007, based upon the recommendations from it ...
    Current Public Domain
  • Licensure of a 13valent pneumococcal conjugate vaccine PCV13 and recommendations for use among children Advisory Committee on Immunization Practices ACIP 2010
    Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.
    United States. Advisory Committee on Immunization Practices.
    March 12, 2010 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On February 24, 2010, a 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.]) was licensed by the Food and Drug Administration (FDA) for prevention of invasive pneumococcal disease (IPD) caused by the 13 pneumococcal serotypes covered by the vaccine and for prevention of otitis media ...
    Superseded Public Domain
  • Licensure of a meningococcal conjugate vaccine Menveo and guidance for use Advisory Committee on Immunization Practices ACIP 2010
    Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.
    United States. Advisory Committee on Immunization Practices.
    March 12, 2010 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On February 19, 2010, the Food and Drug Administration (FDA) licensed a quadrivalent meningococcal conjugate vaccine, MenACWY-CRM (Menveo, Novartis Vaccines and Diagnostics). MenACWY-CRM is licensed as a single dose for use among persons aged 11-55 years. The Advisory Committee on Immunization Practices (ACIP) reviewed data from prelicensure clinic ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports March 12 2010 Vol 59 No RR1
    Morbidity and Mortality Weekly Report: Recommendations and Reports, March 12, 2010 / Vol. 59 / No. RR-1
    Fischer, Marc ;
    Hills, Susan
    March 12, 2010 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "This report updates the 1993 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the prevention of Japanese encephalitis (JE) among travelers (CDC. Inactivated Japanese encephalitis virus vaccine: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 1993;42[No. RR-1]). This report summ ...
    Current Public Domain
  • Technical Instructions for Civil Surgeons 2010
    Technical Instructions for Civil Surgeons [2010]
    03/09/2010
    This document provides guidance to Physicians in the United States who screen applicants adjusting status to remain in the U.S.
    Current Public Domain
  • Designing public swimming facilities
    Designing public swimming facilities
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases.
    3/3/2010 | Fact sheet for pool designers
    Recommendations for the design of swimming facilities with regard to preventing recreational water illnesses.Publication date from document properties.designing-public-swimming-facilities-factsheet.pdf
    Current Public Domain
  • Recommended adult immunization schedule United States 2010
    Recommended adult immunization schedule -- United States, 2010
    United States. Advisory Committee on Immunization Practices.  ...
    January 15, 2010 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The Advisory Committee on Immunization Practices (ACIP) annually reviews the recommended Adult Immunization schedule reflects current recommendations for the licensed vaccines. In October 2009, ACIP approved the Adult Immunization Schedule for 2010, which includes several changes. A bivalent human papillomavirus vaccine (HPV2) was licensed for use ...
    Superseded Public Domain
  • Recommended immunization schedules for persons aged 0 through 18 years United States 2010
    Recommended immunization schedules for persons aged 0 through 18 years -- United States, 2010
    United States. Advisory Committee on Immunization Practices.  ...
    January 8, 2010 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The Advisory Committee on Immunization Practices (ACIP) annually publishes an immunization schedule for persons aged 0 through 18 years that summarizes recommendations for currently licensed vaccines for children aged 18 years and younger and includes recommendations in effect as of December 15, 2009. Changes to the previous schedule (1) include th ...
    Superseded Public Domain
  • Interim planning guidance for preparedness and response to a mass casualty event resulting from terrorist use of explosives
    Interim planning guidance for preparedness and response to a mass casualty event resulting from terrorist use of explosives
    Ashkenazi, Isaac ;
    Basavaraju, Sridhar V.
    2010
    "The purpose of this interim planning guidance is to provide valuable information and insight to help public policy and health system leaders at all levels prepare for and respond to a mass casualty event (MCE) caused by terrorist use of explosives (TUE). Medical preparations for an MCE have traditionally focused on the scene and prehospital sector ...
    Current Public Domain
  • Public health workbook to define locate and reach special vulnerable and atrisk populations in an emergency
    Public health workbook to define, locate and reach special, vulnerable, and at-risk populations in an emergency
    Centers for Disease Control and Prevention (U.S). Office of Public Health Preparedness and Response.
    2010
    "The capacity to reach every person in a community is one of the major goals for emergency preparedness and response. The goal of emergency health communication is to rapidly get the right information to the entire population so that they are able to make the right choices for their health and safety. To do this, a community must know what subgroup ...
    Superseded Public Domain
  • Joint statement on bed bug control in the United States from the US Centers for Disease Control and Prevention CDC and the US Environmental Protection Agency EPA
    Joint statement on bed bug control in the United States from the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Environmental Protection Agency (EPA)
    Centers for Disease Control and Prevention (U.S.)  ...
    2010
    The Centers for Disease Control and Prevention (CDC) and the U.S. Environmental Protection Agency (EPA) developed this document to highlight emerging public health issues associated with bed bugs (Cimex lectularius) in communities throughout the United States.Suggested citation: Centers for Disease Control and Prevention and U.S. Environmental Prot ...
    Current Public Domain
  • Advice for travelers
    Advice for travelers
    Centers for Disease Control and Prevention (U.S.)  ...
    November 2009 | Treatment guidelines from the Medical Letter. 2009; 7(87):83-94; quiz 2 p following 94.
    Treatment Guidelines from The Medical Letter . Patients planning to travel to other countries often ask physicians for information about appropriate vaccines and prevention of diarrhea and malaria. More detailed advice for travelers is available from the Centers for Disease Control and Prevention (CDC) at www.cdc.gov/travel. Guidelines are also ava ...
    Public Domain
  • Preventing dental caries through schoolbased sealant programs updated recommendations and reviews of evidence
    Preventing dental caries through school-based sealant programs: updated recommendations and reviews of evidence.
    November 2009 | Journal of the American Dental Association (1939). 2009; 140(11):1356-65.
    BACKGROUND: School-based sealant programs (SBSPs) increase sealant use and reduce caries. Programs target schools that serve children from low-income families and focus on sealing newly erupted permanent molars. In 2004 and 2005, the Centers for Disease Control and Prevention (CDC), Atlanta, sponsored meetings of an expert work group to update reco ...
    Current Public Domain
  • Evaluation for Improvement A SevenStep Empowerment Evaluation Approach for Violence Prevention Organizations
    Evaluation for Improvement: A Seven-Step Empowerment Evaluation Approach for Violence Prevention Organizations
    Cox, Pamela J. ;
    Craft, Carole A.
    November 2009
    "This manual is designed to help violence prevention organizations hire an empowerment evaluator who will assist them in building their evaluation capacity through a learn-by-doing process of evaluating their own strategies. It is for state and local leaders and staff members of organizations, coalitions, government agencies, and/or partnerships wo ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports October 16 2009 Vol 58 No RR12
    Morbidity and Mortality Weekly Report: Recommendations and Reports, October 16, 2009 / Vol. 58 / No. RR-12
    Gould, L. Hannah ;
    Bopp, Cheryl
    October 16, 2009 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "Shiga toxin--producing Escherichia coli (STEC) are a leading cause of bacterial enteric infections in the United States. Prompt, accurate diagnosis of STEC infection is important because appropriate treatment early in the course of infection might decrease the risk for serious complications such as renal damage and improve overall patient outcome. ...
    Current Public Domain
  • ACCFAHAACP 2009 Competence and Training Statement A Curriculum on Prevention of Cardiovascular Disease
    ACCF/AHA/ACP 2009 Competence and Training Statement: A Curriculum on Prevention of Cardiovascular Disease
    American College of Sports Medicine .  ...
    September 29, 2009 | Circulation. 2009; 120(13):e100-26.
    The American College of Cardiology Foundation (ACCF)/American Heart Association (AHA)/American College of Physicians (ACP) Task Force on Clinical Competence was formed in 1998 to develop recommendations for attaining and maintaining the cognitive and technical skills necessary for the competent performance of a specific cardiovascular service, proc ...
    Current Public Domain
221 - 240 / 779